Segal G H, Edinger M G, Owen M, McNealis M, Lopez P, Perkins A, Linden M D, Fishleder A J, Stoler M H, Tubbs R R
Department of Pathology, Cleveland Clinic Foundation, Ohio 44195.
Cytometry. 1991;12(4):350-9. doi: 10.1002/cyto.990120410.
Accurate and consistent enumeration of B-cell subpopulations in lymphoid tissue was achieved through multiparameter three-color immunofluorescence and flow cytometric analysis (FCM). Phycoerythrin (PE)-anti-CD19 (Leu12) and biotinylated anti-HLADr/streptavidin-Duochrome (PE/Texas Red), used in conjunction with polyclonal fluorescein isothiocyanate (FITC) conjugated anti-surface immunoglobulin (SIg) antibodies, effectively separated non-specific binding and background fluorescence from true B-cell surface FITC immunofluorescence, while concomitantly analyzing for HLADr and CD19 phenotypic expression/deletion. Autofluorescence was measured to establish a fluorescence threshold. A second control measured non-specific binding of isotypic control mouse Ig and non-immune rabbit IgG. Cell suspensions from 128 samples of various lymphoid proliferations were studied. In 116 of the 128 samples, kappa/lambda ratios determined by flow cytometry correlated well with immunocytology results obtained using cytospins from the same cell suspension and with histopathologically established diagnosis. Clonality and lineage as defined immunotypically by flow cytometry was concordant with genotypic results in 64 of the 67 cases evaluated. SIg, HLADr, and CD19 deletions were demonstrated by flow cytometry in 8, 4, and 1 case(s), respectively. Discordance was usually attributable to selective loss of large neoplastic cells in flow cytometry specimens or absent expression of SIg by some cytoplasmic Ig (CIg+) lymphomas.
通过多参数三色免疫荧光和流式细胞术分析(FCM)实现了对淋巴组织中B细胞亚群的准确且一致的计数。藻红蛋白(PE)标记的抗CD19(Leu12)和生物素化的抗HLA-Dr/链霉亲和素-双色荧光染料(PE/德克萨斯红),与多克隆异硫氰酸荧光素(FITC)偶联的抗表面免疫球蛋白(SIg)抗体联合使用,有效地将非特异性结合和背景荧光与真正的B细胞表面FITC免疫荧光区分开来,同时分析HLA-Dr和CD19的表型表达/缺失情况。测量自发荧光以建立荧光阈值。第二个对照测量同型对照小鼠Ig和非免疫兔IgG的非特异性结合。研究了来自128个各种淋巴增殖样本的细胞悬液。在128个样本中的116个中,通过流式细胞术测定的kappa/ lambda比值与使用来自相同细胞悬液的细胞涂片获得的免疫细胞学结果以及组织病理学确诊结果相关性良好。在评估的67例病例中的64例中,通过流式细胞术免疫分型定义的克隆性和谱系与基因型结果一致。通过流式细胞术分别在8例、4例和1例中证实了SIg、HLA-Dr和CD19的缺失。不一致通常归因于流式细胞术标本中大型肿瘤细胞的选择性丢失或某些细胞质Ig(CIg+)淋巴瘤中SIg的缺失表达。